159 related articles for article (PubMed ID: 33506208)
1. An updated histology recode for the analysis of primary malignant and nonmalignant brain and other central nervous system tumors in the Surveillance, Epidemiology, and End Results Program.
Forjaz G; Barnholtz-Sloan JS; Kruchko C; Siegel R; Negoita S; Ostrom QT; Dickie L; Ruhl J; Van Dyke A; Patil N; Cioffi G; Miller KD; Waite K; Mariotto AB
Neurooncol Adv; 2021; 3(1):vdaa175. PubMed ID: 33506208
[TBL] [Abstract][Full Text] [Related]
2. The Central Brain Tumor Registry of the United States Histopathological Grouping Scheme Provides Clinically Relevant Brain and Other Central Nervous System Categories for Cancer Registry Data.
Ostrom Q; Kruchko C; Neff C; Firth A; Sherman R
J Registry Manag; 2022; 49(4):139-152. PubMed ID: 37260822
[TBL] [Abstract][Full Text] [Related]
3. Trends in Pediatric Central Nervous System Tumor Incidence in the United States, 1998-2013.
Withrow DR; Berrington de Gonzalez A; Lam CJK; Warren KE; Shiels MS
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):522-530. PubMed ID: 30464022
[TBL] [Abstract][Full Text] [Related]
4. Primary brain and other central nervous system tumors in the United States (2014-2018): A summary of the CBTRUS statistical report for clinicians.
Low JT; Ostrom QT; Cioffi G; Neff C; Waite KA; Kruchko C; Barnholtz-Sloan JS
Neurooncol Pract; 2022 May; 9(3):165-182. PubMed ID: 35601966
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
6. Brain and other central nervous system tumor statistics, 2021.
Miller KD; Ostrom QT; Kruchko C; Patil N; Tihan T; Cioffi G; Fuchs HE; Waite KA; Jemal A; Siegel RL; Barnholtz-Sloan JS
CA Cancer J Clin; 2021 Sep; 71(5):381-406. PubMed ID: 34427324
[TBL] [Abstract][Full Text] [Related]
7. Mortality trends in primary malignant brain and central nervous system tumors vary by histopathology, age, race, and sex.
Thierheimer M; Cioffi G; Waite KA; Kruchko C; Ostrom QT; Barnholtz-Sloan JS
J Neurooncol; 2023 Mar; 162(1):167-177. PubMed ID: 36928698
[TBL] [Abstract][Full Text] [Related]
8. Nonmalignant meningioma and vestibular schwannoma incidence trends in the United States, 2004-2017.
Withrow DR; Devesa SS; Deapen D; Petkov V; Van Dyke AL; Adamo M; Armstrong TS; Gilbert MR; Linet MS
Cancer; 2021 Oct; 127(19):3579-3590. PubMed ID: 34160068
[TBL] [Abstract][Full Text] [Related]
9. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system.
Kohler BA; Ward E; McCarthy BJ; Schymura MJ; Ries LA; Eheman C; Jemal A; Anderson RN; Ajani UA; Edwards BK
J Natl Cancer Inst; 2011 May; 103(9):714-36. PubMed ID: 21454908
[TBL] [Abstract][Full Text] [Related]
10. Relative survival after diagnosis with a primary brain or other central nervous system tumor in the National Program of Cancer Registries, 2004 to 2014.
Ostrom QT; Truitt G; Gittleman H; Brat DJ; Kruchko C; Wilson R; Barnholtz-Sloan JS
Neurooncol Pract; 2020 Jun; 7(3):306-312. PubMed ID: 32537180
[TBL] [Abstract][Full Text] [Related]
11. Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013.
Walker EV; Davis FG;
Neuro Oncol; 2019 Feb; 21(3):360-369. PubMed ID: 30649461
[TBL] [Abstract][Full Text] [Related]
12. Survival rates of children and young adolescents with CNS tumors improved in the Netherlands since 1990: A population-based study.
Hoogendijk R; van der Lugt J; van Vuurden D; Kremer L; Wesseling P; Hoving E; Karim-Kos HE
Neurooncol Adv; 2022; 4(1):vdab183. PubMed ID: 35591979
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system tumours among adolescents and young adults (15-39 years) in Southern and Eastern Europe: Registration improvements reveal higher incidence rates compared to the US.
Georgakis MK; Panagopoulou P; Papathoma P; Tragiannidis A; Ryzhov A; Zivkovic-Perisic S; Eser S; Taraszkiewicz Ł; Sekerija M; Žagar T; Antunes L; Zborovskaya A; Bastos J; Florea M; Coza D; Demetriou A; Agius D; Strahinja RM; Sfakianos G; Nikas I; Kosmidis S; Razis E; Pourtsidis A; Kantzanou M; Dessypris N; Petridou ET
Eur J Cancer; 2017 Nov; 86():46-58. PubMed ID: 28961466
[TBL] [Abstract][Full Text] [Related]
14. Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.
Georgakis MK; Papathoma P; Ryzhov A; Zivkovic-Perisic S; Eser S; Taraszkiewicz Ł; Sekerija M; Žagar T; Antunes L; Zborovskaya A; Bastos J; Florea M; Coza D; Demetriou A; Agius D; Strahinja RM; Themistocleous M; Tolia M; Tzanis S; Alexiou GA; Papanikolaou PG; Nomikos P; Kantzanou M; Dessypris N; Pourtsidis A; Petridou ET
Cancer; 2017 Nov; 123(22):4458-4471. PubMed ID: 28708937
[TBL] [Abstract][Full Text] [Related]
15. Incidence trends, rates, and ethnic variations of primary CNS tumors in Texas from 1995 to 2013.
Ambe SN; Lyon KA; Nizamutdinov D; Fonkem E
Neurooncol Pract; 2018 Aug; 5(3):154-160. PubMed ID: 30094045
[TBL] [Abstract][Full Text] [Related]
16. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
17. Brain, other central nervous system, and eye cancer.
Polednak AP; Flannery JT
Cancer; 1995 Jan; 75(1 Suppl):330-7. PubMed ID: 8001004
[TBL] [Abstract][Full Text] [Related]
18. Case-Completeness of Nonmalignant Central Nervous System Tumors in the Canadian Cancer Registry, 2011-2015.
Zakaria D; Shaw A; Woods R; De P; Davis F
J Registry Manag; 2018; 45(1):117-131. PubMed ID: 31017881
[TBL] [Abstract][Full Text] [Related]
19. Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001.
Deorah S; Lynch CF; Sibenaller ZA; Ryken TC
Neurosurg Focus; 2006 Apr; 20(4):E1. PubMed ID: 16709014
[TBL] [Abstract][Full Text] [Related]
20. Incidence patterns of childhood non-Wilms renal tumors: Comparing data of the Nationwide Registry of Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST), Greece, and the Surveillance, Epidemiology, and End Results Program (SEER), USA.
Doganis D; Karalexi MA; ; Panagopoulou P; Bouka P; Bouka E; Markozannes G; Ntzani EE; Steliarova-Foucher E; Petridou ET
Cancer Epidemiol; 2022 Jun; 78():102153. PubMed ID: 35390585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
